On September 20, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that its President and Chief Executive Officer, Rodney Varner, will be participating in two investor conferences in September 2021 (Press release, Genprex, SEP 20, 2021, View Source [SID1234587996]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
CEO Roadshow Webinar
· Format: Company presentation
· Presentation Date/Time: September 22, 2021 at 11:00 a.m. ET
· Access: https://bit.ly/3eoHeie
The CEO Roadshow webinar series features small and mid-cap stocks that are on the verge of a breakout or have other near-term developments making them an attractive long-term investment opportunity.
Benzinga Healthcare Small Cap Conference (September 28-29, 2021)
Format: Company presentation
Presentation Date/Time: September 29, 2021 at 1:15 p.m. ET
Access: View Source
Benzinga Small Cap Conferences bridge the gap between Small Cap companies, investors, and traders by providing a forum to learn about a curated group of Small Cap investment opportunities, and connect with the healthcare Small Cap audience in an intimate, virtual setting.
Mr. Varner will be available for questions following each company presentation. The presentations will be recorded and available for replay on Genprex’s website for a period of time.